Moderna is developing a new vaccine for young children amid the ongoing COVID-19 pandemic.
Researchers at the University of Colorado School of Medicine are conducting a new vaccine trial with the end goal of making an updated vaccine for kids 6 months to 5 years old, CBS News reported Tuesday.
Moderna previously developed an updated vaccine that includes protection against Omicron and its newer subvariants. Unfortunately, the bivalent booster was only for adults. An updated dose for kids has yet to be made.
The U.S. Centers for Disease Control and Prevention (CDC) officially recommended the bivalent boosters last September, saying the new doses could restore and ensure the protection of people aged 12 and above from SARS-CoV-2 and its newer, more transmissible variants.
With the new trial, clinical research nurse Tori Rutherford told the outlet that Moderna would make a bivalent booster for younger children.